{"nct_id":"NCT00337467","title":"Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic Suppression","status":"COMPLETED","status_verified_date":"2010-06","start_date":"2006-06","start_date_type":null,"primary_completion_date":"2008-05","primary_completion_date_type":"ACTUAL","completion_date":"2009-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}